|Bid||6.36 x N/A|
|Ask||6.42 x N/A|
|Day's Range||6.19 - 6.42|
|52 Week Range||3.45 - 11.04|
|Beta (3Y Monthly)||0.87|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Organigram earnings missed Q3 views. Aurora Cannabis got two new cultivation licenses. Organigram, Aurora and other marijuana stocks rose.
Aurora Cannabis Inc. (NYSE: ACB) said Monday it has obtained Health Canada licenses for outdoor cannabis cultivation in Canada, and also a processing license for its Aurora Air facility, where the company’s new edible products will be manufactured. The company will use two new sites for cannabis cultivation research, one being located in British Columbia and the other in Quebec. Benzinga's Cannabis Capital Conference heads to Detroit on Aug. 15 -- Click here to learn more!
Canadian cannabis companies have leapt onto U.S. stock markets, dazzling investors. Here's a rundown of industry facts and how to invest in marijuana stocks.
Chief Financial Officer Mike Lee told Jefferies analyst Ryan Tomkins that earnings before interest, taxes, depreciation and amortization could be negative for the next 2 fiscal years.
From acquisitions to equity investments, the North American hemp industry has been awash in capital investment since the Farm Bill 2018 was federally passed in the United States last December. The Hemp Business Journal has been closely monitoring such activity, and will soon publish more comprehensive data pertaining to the latest deals. Arguably the biggest deal in the hemp industry so far this year has been the acquisition of Manitoba Harvest by Tilray (NASDAQ: TLRY).
Analysts say nation will turn a new leaf, changing federal law within a few years, as cannabis industry expected to grow big time over next decade.
Aurora's focus on medical marijuana patients and international expansion could put these three companies on its buyout radar.
For the United States, recreational cannabis and medicinal cannabis have penetrated just 8% and 21% of their estimated markets, leading to our expectation for 25% and 15% compound annual growth rates through 2030, respectively. For Canada, despite recent recreational legalization, cannabis has penetrated just 12% of our estimated market, setting the stage for a 20% CAGR through 2030. For the international market (which excludes Canada and the United States), we forecast market potential of nearly $43 billion and a 23% CAGR through 2030 as more and more countries recognize the benefits of medical cannabis.
An emerging data company has a unique solution to identify, manage and distribute cannabis products, but the potential of its technology could stretch beyond the booming marijuana markets
Add another marijuana stock to the exchange's lineup, and join the growing crowd ordering burritos at the popular Mexican fast-casual restaurant chain.
Aurora might be late to the battle in the U.S., but the company just might eventually claim the throne in the global hemp CBD market.
The cannabis industry is booming. Compelling growth opportunities are leading to an incredible amount of investor interest. Read around the web and you will see that 8 out of 10 times, Canopy Growth Corporation is in the top two, and for good reason.
You'd have a lot of extra green in your pocket if you've owned any of these popular pot stocks since the year began.
As part of the agreement, mixed martial arts organization Bellator MMA will give cbdMD exclusive branding rights inside the Bellator cage. CbdMD president Caryn Dunayer said in the press release the partnership will position the company to "educate athletes and fans" about the multiple benefits of CBD. Need more cannabis news?